Catalyst Health Ventures
Venture Capital
Active
Boston, United States
12
31M
11
0.75
0.08
2
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.75
- Follow on index
- 0.08
- Investments by industry
- Medical Device (10)
- Health Care (9)
- Biotechnology (6)
- Medical (4)
- Health Diagnostics (4) Show 13 more
- Investments by region
-
- United States (12)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 56M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 11.17
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Antlos | 25 Jun 2015 | Marketplace, Information and Communications Technology (ICT), Travel, Tourism, Boating, Sailing | Seed | 590K | Italy, Veneto |
| Brixton Biosciences | 14 May 2024 | Biotechnology, Information Technology, Life Science | Early Stage Venture | 33M | United States, Massachusetts, Cambridge |
| Sera Prognostics | 10 Jan 2017 | Biotechnology, Health Care, Hospital, Medical Device, Medical | Late Stage Venture | 40M | Salt Lake City, Utah, United States |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.